1. Home
  2. ACAD vs HGV Comparison

ACAD vs HGV Comparison

Compare ACAD & HGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$26.64

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Hilton Grand Vacations Inc.

HGV

Hilton Grand Vacations Inc.

HOLD

Current Price

$47.49

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACAD
HGV
Founded
1993
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
ACAD
HGV
Price
$26.64
$47.49
Analyst Decision
Buy
Buy
Analyst Count
22
7
Target Price
$30.00
$49.71
AVG Volume (30 Days)
1.3M
792.6K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
98.53
N/A
EPS
1.54
0.56
Revenue
$1,047,118,000.00
$4,470,000,000.00
Revenue This Year
$15.16
$14.47
Revenue Next Year
$11.51
$9.57
P/E Ratio
$17.46
$84.42
Revenue Growth
12.69
5.47
52 Week Low
$13.40
$30.59
52 Week High
$28.35
$52.08

Technical Indicators

Market Signals
Indicator
ACAD
HGV
Relative Strength Index (RSI) 51.54 68.83
Support Level $26.55 $44.77
Resistance Level $27.74 $46.70
Average True Range (ATR) 0.72 1.13
MACD -0.19 0.14
Stochastic Oscillator 38.35 89.33

Price Performance

Historical Comparison
ACAD
HGV

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

About HGV Hilton Grand Vacations Inc.

Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.

Share on Social Networks: